| 0 |
AUTOIMMUNE ENDOCRINE DISORDER |
1 |
0.0476 |
| 1 |
RADIATION RETINOPATHY |
1 |
0.0435 |
| 2 |
METASTATIC OCULAR MELANOMA |
1 |
0.0400 |
| 3 |
ASCARIASIS |
1 |
0.0303 |
| 4 |
IMMUNE-MEDIATED CHOLESTASIS |
1 |
0.0270 |
| 5 |
IMMUNE-MEDIATED GASTROINTESTINAL DISORDER |
1 |
0.0233 |
| 6 |
BRAIN EMPYEMA |
1 |
0.0179 |
| 7 |
VISCERAL VENOUS THROMBOSIS |
1 |
0.0167 |
| 8 |
INTESTINAL MUCOSAL ATROPHY |
1 |
0.0100 |
| 9 |
IMMUNE-MEDIATED MYASTHENIA GRAVIS |
3 |
0.0092 |
| 10 |
MELANOSIS |
1 |
0.0089 |
| 11 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
2 |
0.0088 |
| 12 |
AUTOIMMUNE LUNG DISEASE |
1 |
0.0085 |
| 13 |
TUMOUR HYPERPROGRESSION |
2 |
0.0081 |
| 14 |
IMMUNE-MEDIATED ENDOCRINOPATHY |
1 |
0.0067 |
| 15 |
DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA |
1 |
0.0055 |
| 16 |
RENAL EMBOLISM |
1 |
0.0054 |
| 17 |
MYXOEDEMA |
1 |
0.0045 |
| 18 |
SARCOID-LIKE REACTION |
1 |
0.0039 |
| 19 |
IMMUNE-MEDIATED MYOCARDITIS |
6 |
0.0037 |
| 20 |
MONKEYPOX |
1 |
0.0036 |
| 21 |
BULBAR PALSY |
1 |
0.0036 |
| 22 |
IMMUNE-MEDIATED MYOSITIS |
9 |
0.0033 |
| 23 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
1 |
0.0030 |
| 24 |
VIRAL DIARRHOEA |
1 |
0.0029 |
| 25 |
IMMUNE-MEDIATED CHOLANGITIS |
1 |
0.0028 |
| 26 |
IMMUNE-MEDIATED ARTHRITIS |
1 |
0.0026 |
| 27 |
IMMUNE-MEDIATED PANCREATITIS |
1 |
0.0026 |
| 28 |
MYASTHENIC SYNDROME |
2 |
0.0026 |
| 29 |
SKIN NEOPLASM EXCISION |
2 |
0.0026 |
| 30 |
GIANT CELL ARTERITIS |
2 |
0.0024 |
| 31 |
MELANOMA RECURRENT |
1 |
0.0024 |
| 32 |
AUTOIMMUNE MYOSITIS |
1 |
0.0021 |
| 33 |
PRODUCT STORAGE ISSUE |
8 |
0.0021 |
| 34 |
IMMUNE-MEDIATED THYROIDITIS |
1 |
0.0020 |
| 35 |
IMMUNE-MEDIATED DERMATITIS |
2 |
0.0020 |
| 36 |
IMMUNE-MEDIATED HEPATITIS |
4 |
0.0020 |
| 37 |
EPIGLOTTITIS |
1 |
0.0018 |
| 38 |
RADIATION NECROSIS |
1 |
0.0017 |
| 39 |
METASTATIC MALIGNANT MELANOMA |
4 |
0.0017 |
| 40 |
VITILIGO |
4 |
0.0017 |
| 41 |
MYOCARDITIS |
19 |
0.0017 |
| 42 |
CORTISOL INCREASED |
1 |
0.0016 |
| 43 |
GLIOMA |
1 |
0.0016 |
| 44 |
OESOPHAGEAL ACHALASIA |
1 |
0.0016 |
| 45 |
AUTOIMMUNE COLITIS |
1 |
0.0016 |
| 46 |
MYASTHENIA GRAVIS |
12 |
0.0015 |
| 47 |
LICHEN SCLEROSUS |
1 |
0.0015 |
| 48 |
CYTOKINE STORM |
1 |
0.0015 |
| 49 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
0.0014 |
| 50 |
DELUSIONAL DISORDER, UNSPECIFIED TYPE |
1 |
0.0013 |
| 51 |
TRACHEITIS |
1 |
0.0013 |
| 52 |
OPHTHALMOPLEGIA |
2 |
0.0013 |
| 53 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 54 |
HEPATIC HAEMORRHAGE |
1 |
0.0012 |
| 55 |
PANCREATIC FAILURE |
2 |
0.0011 |
| 56 |
MICROANGIOPATHY |
1 |
0.0011 |
| 57 |
SOLAR LENTIGO |
1 |
0.0011 |
| 58 |
INJECTION SITE SCAB |
1 |
0.0010 |
| 59 |
MUCOSAL DISORDER |
1 |
0.0010 |
| 60 |
HYPOGONADISM |
1 |
0.0010 |
| 61 |
KERATITIS |
3 |
0.0010 |
| 62 |
CAPILLARY LEAK SYNDROME |
2 |
0.0010 |
| 63 |
THYROID HORMONES INCREASED |
1 |
0.0010 |
| 64 |
POLYMYALGIA RHEUMATICA |
3 |
0.0009 |
| 65 |
TROPONIN INCREASED |
7 |
0.0009 |
| 66 |
TUMOUR PSEUDOPROGRESSION |
1 |
0.0009 |
| 67 |
HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME |
1 |
0.0009 |
| 68 |
MYOCARDIAL INJURY |
1 |
0.0009 |
| 69 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
1 |
0.0009 |
| 70 |
CORTISOL DECREASED |
1 |
0.0009 |
| 71 |
COLITIS MICROSCOPIC |
4 |
0.0008 |
| 72 |
GUILLAIN-BARRE SYNDROME |
4 |
0.0008 |
| 73 |
METASTASES TO PERITONEUM |
2 |
0.0008 |
| 74 |
PRODUCT PREPARATION ISSUE |
5 |
0.0008 |
| 75 |
ENCEPHALITIS AUTOIMMUNE |
1 |
0.0008 |
| 76 |
HYPOTHALAMO-PITUITARY DISORDER |
1 |
0.0007 |
| 77 |
MYASTHENIA GRAVIS CRISIS |
1 |
0.0007 |
| 78 |
MYOSITIS |
6 |
0.0007 |
| 79 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
1 |
0.0007 |
| 80 |
SMALL CELL LUNG CANCER |
1 |
0.0007 |
| 81 |
IMMUNE-MEDIATED ADVERSE REACTION |
1 |
0.0007 |
| 82 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 83 |
LINEAR IGA DISEASE |
1 |
0.0006 |
| 84 |
ATRIOVENTRICULAR BLOCK COMPLETE |
4 |
0.0006 |
| 85 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 86 |
TREATMENT DELAYED |
1 |
0.0006 |
| 87 |
IMMUNE-MEDIATED LUNG DISEASE |
1 |
0.0005 |
| 88 |
ADRENAL DISORDER |
1 |
0.0005 |
| 89 |
TYPE 1 DIABETES MELLITUS |
3 |
0.0005 |
| 90 |
EXTRAVASATION |
2 |
0.0005 |
| 91 |
METASTASIS |
3 |
0.0004 |
| 92 |
HYPOVOLAEMIC SHOCK |
2 |
0.0004 |
| 93 |
PANNICULITIS |
1 |
0.0004 |
| 94 |
BRAIN ABSCESS |
1 |
0.0004 |
| 95 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 96 |
CANCER PAIN |
1 |
0.0004 |
| 97 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
2 |
0.0004 |
| 98 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 99 |
LIPOMA |
1 |
0.0004 |
| 100 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 101 |
FINE MOTOR SKILL DYSFUNCTION |
1 |
0.0003 |
| 102 |
COLITIS |
13 |
0.0003 |
| 103 |
MALIGNANT NEOPLASM PROGRESSION |
35 |
0.0003 |
| 104 |
BRAIN HERNIATION |
1 |
0.0003 |
| 105 |
THYROIDITIS |
1 |
0.0003 |
| 106 |
ADRENAL INSUFFICIENCY |
4 |
0.0003 |
| 107 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 108 |
DERMATITIS ACNEIFORM |
2 |
0.0003 |
| 109 |
BLOOD BLISTER |
1 |
0.0003 |
| 110 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 111 |
MALIGNANT MELANOMA |
4 |
0.0003 |
| 112 |
EYELID PTOSIS |
3 |
0.0003 |
| 113 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 114 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 115 |
HYPOTHYROIDISM |
9 |
0.0003 |
| 116 |
HEPATITIS |
7 |
0.0003 |
| 117 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 118 |
RETINOPATHY |
1 |
0.0003 |
| 119 |
TUBULOINTERSTITIAL NEPHRITIS |
5 |
0.0003 |
| 120 |
PEMPHIGOID |
2 |
0.0003 |
| 121 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 122 |
AZOTAEMIA |
1 |
0.0003 |
| 123 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 124 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 125 |
LUNG NEOPLASM |
1 |
0.0002 |
| 126 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0002 |
| 127 |
TENSION HEADACHE |
1 |
0.0002 |
| 128 |
HEPATOTOXICITY |
5 |
0.0002 |
| 129 |
UVEITIS |
3 |
0.0002 |
| 130 |
PNEUMONITIS |
6 |
0.0002 |
| 131 |
URINE ABNORMALITY |
1 |
0.0002 |
| 132 |
ACUTE HEPATIC FAILURE |
3 |
0.0002 |
| 133 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
2 |
0.0002 |
| 134 |
PRODUCT STORAGE ERROR |
19 |
0.0002 |
| 135 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 136 |
CARDIOMYOPATHY |
3 |
0.0002 |
| 137 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 138 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 139 |
THYROID DISORDER |
3 |
0.0002 |
| 140 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 141 |
POLYARTHRITIS |
1 |
0.0002 |
| 142 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 143 |
SKIN TOXICITY |
1 |
0.0002 |
| 144 |
METABOLIC DISORDER |
1 |
0.0002 |
| 145 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 146 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 147 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
1 |
0.0002 |
| 148 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 149 |
CHOLANGITIS |
1 |
0.0002 |
| 150 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 151 |
ENTERITIS |
1 |
0.0002 |
| 152 |
COLITIS ISCHAEMIC |
1 |
0.0001 |
| 153 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 154 |
JOINT EFFUSION |
1 |
0.0001 |
| 155 |
ENCEPHALITIS |
1 |
0.0001 |
| 156 |
AUTOIMMUNE HEPATITIS |
1 |
0.0001 |
| 157 |
ADVERSE EVENT |
13 |
0.0001 |
| 158 |
THERMAL BURN |
1 |
0.0001 |
| 159 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 160 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 161 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 162 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 163 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 164 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 165 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 166 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 167 |
BLOOD POTASSIUM INCREASED |
2 |
0.0001 |
| 168 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 169 |
MYOPATHY |
1 |
0.0001 |
| 170 |
DIPLOPIA |
3 |
0.0001 |
| 171 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 172 |
NAIL DISORDER |
1 |
0.0001 |
| 173 |
NEUROTOXICITY |
2 |
0.0001 |
| 174 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 175 |
PURPURA |
1 |
0.0001 |
| 176 |
CARDIOTOXICITY |
1 |
0.0001 |
| 177 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 178 |
IRON DEFICIENCY ANAEMIA |
1 |
0.0001 |
| 179 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 180 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 181 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 182 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 183 |
RECALLED PRODUCT ADMINISTERED |
1 |
0.0001 |
| 184 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 185 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 186 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 187 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 188 |
HOSPICE CARE |
1 |
0.0001 |
| 189 |
PRESCRIBED UNDERDOSE |
2 |
0.0001 |
| 190 |
SLUGGISHNESS |
1 |
0.0001 |
| 191 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 192 |
PERITONITIS |
2 |
0.0001 |
| 193 |
PETECHIAE |
1 |
0.0001 |
| 194 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 195 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 196 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 197 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 198 |
STEVENS-JOHNSON SYNDROME |
2 |
0.0001 |
| 199 |
MALNUTRITION |
1 |
0.0001 |
| 200 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 201 |
DEATH |
76 |
0.0001 |
| 202 |
METASTASES TO LUNG |
1 |
0.0001 |
| 203 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 204 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 205 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 206 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 207 |
BRAIN OEDEMA |
1 |
0.0001 |
| 208 |
BEDRIDDEN |
1 |
0.0001 |
| 209 |
ADVERSE REACTION |
1 |
0.0001 |
| 210 |
GINGIVAL BLEEDING |
1 |
0.0001 |
| 211 |
SKIN LESION |
2 |
0.0001 |
| 212 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 213 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 214 |
SUBDURAL HAEMATOMA |
1 |
0.0001 |
| 215 |
OFF LABEL USE |
60 |
0.0001 |
| 216 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 217 |
ASCITES |
2 |
0.0001 |
| 218 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 219 |
APHASIA |
2 |
0.0001 |
| 220 |
INSURANCE ISSUE |
1 |
0.0001 |
| 221 |
LYMPHOMA |
1 |
0.0001 |
| 222 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 223 |
NIGHT SWEATS |
2 |
0.0001 |
| 224 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 225 |
METASTASES TO BONE |
1 |
0.0001 |
| 226 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 227 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 228 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 229 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 230 |
SCAR |
1 |
0.0001 |
| 231 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 232 |
METASTASES TO LIVER |
1 |
0.0001 |
| 233 |
PANCREATITIS |
3 |
0.0001 |
| 234 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 235 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 236 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 237 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 238 |
THIRST |
1 |
0.0001 |
| 239 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 240 |
CHOLESTASIS |
1 |
0.0001 |
| 241 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 242 |
EAR PAIN |
1 |
0.0001 |
| 243 |
HAEMORRHOIDS |
1 |
0.0001 |
| 244 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 245 |
DISABILITY |
1 |
0.0001 |
| 246 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 247 |
PLEURAL EFFUSION |
3 |
0.0000 |
| 248 |
BLINDNESS |
2 |
0.0000 |
| 249 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 250 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 251 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 252 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 253 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 254 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 255 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 256 |
ORAL PAIN |
1 |
0.0000 |
| 257 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 258 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 259 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 260 |
RENAL DISORDER |
2 |
0.0000 |
| 261 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 262 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 263 |
PRESYNCOPE |
1 |
0.0000 |
| 264 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 265 |
HOSPITALISATION |
6 |
0.0000 |
| 266 |
ILLNESS |
4 |
0.0000 |
| 267 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 268 |
HAEMATOMA |
1 |
0.0000 |
| 269 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 270 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 271 |
JAUNDICE |
1 |
0.0000 |
| 272 |
RASH PRURITIC |
2 |
0.0000 |
| 273 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 274 |
DIVERTICULITIS |
1 |
0.0000 |
| 275 |
DEMENTIA |
1 |
0.0000 |
| 276 |
THROMBOCYTOPENIA |
4 |
0.0000 |
| 277 |
BLISTER |
2 |
0.0000 |
| 278 |
HYPONATRAEMIA |
2 |
0.0000 |
| 279 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 280 |
MYALGIA |
6 |
0.0000 |
| 281 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 282 |
DECREASED APPETITE |
8 |
0.0000 |
| 283 |
DYSPHONIA |
2 |
0.0000 |
| 284 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 285 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 286 |
EPILEPSY |
1 |
0.0000 |
| 287 |
WEIGHT DECREASED |
9 |
0.0000 |
| 288 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 289 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 290 |
HIP FRACTURE |
1 |
0.0000 |
| 291 |
OSTEONECROSIS |
1 |
0.0000 |
| 292 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 293 |
VIRAL INFECTION |
1 |
0.0000 |
| 294 |
LIP SWELLING |
1 |
0.0000 |
| 295 |
RASH |
13 |
0.0000 |
| 296 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 297 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 298 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 299 |
RASH MACULAR |
1 |
0.0000 |
| 300 |
HEART RATE DECREASED |
1 |
0.0000 |
| 301 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 302 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 303 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 304 |
INFLUENZA |
3 |
0.0000 |
| 305 |
SEPSIS |
3 |
0.0000 |
| 306 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 307 |
SEIZURE |
3 |
0.0000 |
| 308 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 309 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 310 |
BACK PAIN |
6 |
0.0000 |
| 311 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 312 |
FATIGUE |
19 |
0.0000 |
| 313 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 314 |
OSTEOPOROSIS |
1 |
0.0000 |
| 315 |
HYPERTENSION |
5 |
0.0000 |
| 316 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 317 |
HYPOACUSIS |
1 |
0.0000 |
| 318 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 319 |
LIVER DISORDER |
1 |
0.0000 |
| 320 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 321 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 322 |
SKIN IRRITATION |
1 |
0.0000 |
| 323 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 324 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 325 |
SWELLING |
2 |
0.0000 |
| 326 |
COMA |
1 |
0.0000 |
| 327 |
ANAEMIA |
4 |
0.0000 |
| 328 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 329 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 330 |
DRY EYE |
1 |
0.0000 |
| 331 |
FLUSHING |
2 |
0.0000 |
| 332 |
FLUID RETENTION |
1 |
0.0000 |
| 333 |
SINUSITIS |
2 |
0.0000 |
| 334 |
THERAPY CESSATION |
1 |
0.0000 |
| 335 |
SPEECH DISORDER |
1 |
0.0000 |
| 336 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 337 |
DIARRHOEA |
12 |
0.0000 |
| 338 |
OEDEMA |
1 |
0.0000 |
| 339 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 340 |
ARTHROPATHY |
1 |
0.0000 |
| 341 |
NECK PAIN |
1 |
0.0000 |
| 342 |
PANCYTOPENIA |
1 |
0.0000 |
| 343 |
WEIGHT INCREASED |
4 |
0.0000 |
| 344 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 345 |
EYE PAIN |
1 |
0.0000 |
| 346 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 347 |
LETHARGY |
1 |
0.0000 |
| 348 |
WHEEZING |
1 |
0.0000 |
| 349 |
ARTHRALGIA |
7 |
0.0000 |
| 350 |
CATARACT |
1 |
0.0000 |
| 351 |
STOMATITIS |
1 |
0.0000 |
| 352 |
FEELING HOT |
1 |
0.0000 |
| 353 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 354 |
CHEST PAIN |
3 |
0.0000 |
| 355 |
PRURITUS |
6 |
0.0000 |
| 356 |
PSORIASIS |
2 |
0.0000 |
| 357 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 358 |
DEHYDRATION |
2 |
0.0000 |
| 359 |
VISION BLURRED |
2 |
0.0000 |
| 360 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 361 |
HEADACHE |
9 |
0.0000 |
| 362 |
COUGH |
4 |
0.0000 |
| 363 |
SLEEP DISORDER |
1 |
0.0000 |
| 364 |
DYSPNOEA |
8 |
0.0000 |
| 365 |
MOBILITY DECREASED |
1 |
0.0000 |
| 366 |
INFECTION |
2 |
0.0000 |
| 367 |
EPISTAXIS |
1 |
0.0000 |
| 368 |
HYPOAESTHESIA |
2 |
0.0000 |
| 369 |
ASTHENIA |
5 |
0.0000 |
| 370 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 371 |
VOMITING |
6 |
0.0000 |
| 372 |
ARTHRITIS |
1 |
0.0000 |
| 373 |
CARDIAC FAILURE |
1 |
0.0000 |
| 374 |
THROMBOSIS |
1 |
0.0000 |
| 375 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 376 |
DRY MOUTH |
1 |
0.0000 |
| 377 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 378 |
CARDIAC ARREST |
1 |
0.0000 |
| 379 |
TREATMENT FAILURE |
1 |
0.0000 |
| 380 |
TREMOR |
2 |
0.0000 |
| 381 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 382 |
URTICARIA |
2 |
0.0000 |
| 383 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 384 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 385 |
COVID-19 |
2 |
0.0000 |
| 386 |
PAIN |
7 |
0.0000 |
| 387 |
TACHYCARDIA |
1 |
0.0000 |
| 388 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 389 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 390 |
CONTUSION |
1 |
0.0000 |
| 391 |
DYSPEPSIA |
1 |
0.0000 |
| 392 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 393 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 394 |
CONSTIPATION |
2 |
0.0000 |
| 395 |
MALAISE |
4 |
0.0000 |
| 396 |
FALL |
3 |
0.0000 |
| 397 |
NAUSEA |
7 |
0.0000 |
| 398 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 399 |
PALPITATIONS |
1 |
0.0000 |
| 400 |
CHILLS |
1 |
0.0000 |
| 401 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 402 |
FEELING ABNORMAL |
2 |
0.0000 |
| 403 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 404 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 405 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 406 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 407 |
RENAL FAILURE |
1 |
0.0000 |
| 408 |
NEUTROPENIA |
1 |
0.0000 |
| 409 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 410 |
PARAESTHESIA |
1 |
0.0000 |
| 411 |
DRUG INTERACTION |
1 |
0.0000 |
| 412 |
PNEUMONIA |
2 |
0.0000 |
| 413 |
PYREXIA |
2 |
0.0000 |
| 414 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 415 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 416 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 417 |
SOMNOLENCE |
1 |
0.0000 |
| 418 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 419 |
ERYTHEMA |
1 |
0.0000 |
| 420 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 421 |
DRUG INEFFECTIVE |
5 |
0.0000 |
| 422 |
INSOMNIA |
1 |
0.0000 |
| 423 |
CONDITION AGGRAVATED |
1 |
0.0000 |